Tian, Y., Zhao, Q., Li, Y., Fan, L., Zhang, Z., Zhao, X., . . . Yang, P. (2021). Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma. Gastroenterol Res Pract.
Citação norma ChicagoTian, Yuan, Qun Zhao, Yong Li, Liqiao Fan, Zhidong Zhang, Xuefeng Zhao, Bibo Tan, Dong Wang, and Peigang Yang. "Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients With Resectable Gastric or Gastroesophageal Junction Adenocarcinoma." Gastroenterol Res Pract 2021.
MLA CitationTian, Yuan, et al. "Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients With Resectable Gastric or Gastroesophageal Junction Adenocarcinoma." Gastroenterol Res Pract 2021.